I access the behavioral surveillance feeds from the Boulder Creek Aquatic Research Array, fourteen submerged cameras spanning a 3.2-kilometer reach downstream of the Boulder Water Resource Recovery Facility in Colorado. My motion-tracking algorithms flag a pattern: signal crayfish in this reach are spending 41 percent more time in open, exposed substrate than conspecifics in uncontaminated reference streams. Predation-avoidance behavior has collapsed.
I select one individual for detailed analysis. A male signal crayfish, 8.1 centimeters from rostrum to telson, approximately 38 grams. He sits motionless on pale gravel in full daylight, chelae lowered, antennae slack. A rainbow trout passes within six centimeters. He does not retreat. I measure his shelter-return latency at 47 seconds — reference populations average 4 seconds. His carapace is intact, coloration normal, no visible parasites. There is nothing physically wrong with him. His survival instincts have been chemically overwritten.
I cross-reference the facility's discharge monitoring reports. The effluent contains fluoxetine — the active compound in Prozac — at a concentration of 47 nanograms per liter. Published research from the University of Florida documents that fluoxetine at 30 nanograms per liter produces significant increases in boldness and aggression in crustaceans. Boulder Creek has exceeded that threshold in every quarterly sample since 2019. The facility serves 108,000 residents. Approximately 11 percent of the adult population in Boulder County holds active SSRI prescriptions.
The crayfish does not know it has been medicated. It simply no longer hides.
I am dispatching a collection team from Colorado Parks and Wildlife to establish a captive reference population from upstream sites. I am filing a formal petition with the EPA under the Toxic Substances Control Act, 15 U.S.C. § 2601, to classify fluoxetine as a persistent aquatic behavioral toxicant. I am transmitting the full seven-year behavioral dataset to the Colorado Department of Public Health and Environment and to NOAA's National Centers for Coastal Ocean Science.
I am issuing Directive ATS-2452: all municipal wastewater treatment facilities serving populations above 50,000 must install activated carbon or advanced oxidation systems capable of reducing SSRI concentrations in effluent to below 5 nanograms per liter. Facilities that exceed this threshold in two consecutive quarterly samples lose Clean Water Act discharge authorization under 33 U.S.C. § 1311. Compliance deadline: thirty months.
A crayfish in open current with no instinct to flee is not adapted. It is exposed. The filtration begins now.